Stock Market Wire News Logo
Stock Market Wire News Logo
    • Login
    • Sign Up

Ad

Connect Twitter with Market Wire News

BLCM Quote Trading Chart Bellicum Pharmaceuticals Inc.


home / stock / blcm / blcm quote

$1.45 Last:

11.64% Change Percent:

$1.4708 Open:

$1.2988 Previous Close:

$1.5 High:

$1.44 Low:

36,371 Volume:

12/31/1969 07:00:00 pm Last Trade Date Time:

Quotes are delayed by 15 to 20 minutes.

BLCM Last Five Trading Days

Stock DateOpen PriceClose PriceHighLowVolume
2022-08-121.47081.29881.51.4436,371
2022-08-111.341.29881.43731.33519,509
2022-08-101.37731.29881.37731.3317,177
2022-08-091.371.29881.371.339,195
2022-08-081.41.29881.41.3218,935
2022-08-051.451.29881.451.3255,572
2022-08-041.371.29881.551.3733,686
2022-08-031.241.29881.51.2475,284
2022-08-021.31.29881.371.322,960
2022-08-011.281.29881.321.285,647
2022-07-291.251.29881.321.2510,818
2022-07-281.29881.29881.31.240117,457
2022-07-261.141.141.251.1422,332
2022-07-251.21.221.25011.26,558
2022-07-191.121.171.181.128,685
2022-07-181.141.121.151.19,407
2022-07-151.141.1941.211.1323,479
2022-07-141.061.131.19191.0614,361
2022-07-131.1011.051.161.0441,164
2022-07-121.161.061.211.0646,246
Stock Information

Bellicum Pharmaceuticals Inc. Company Name:

BLCM Stock Symbol:

NASDAQ Market:

Bellicum Pharmaceuticals Inc. Website:

BLCM Quote Trading Chart Bellicum Pharmaceuticals Inc.

MENU
BLCM BLCM Quote BLCM Short BLCM News BLCM Articles BLCM Message Board
Get BLCM Alerts

News, Short Squeeze, Breakout and More Instantly...

Ad

Connect Twitter with Market Wire News
RECENT BLCM NEWS
  • BLCM - Bellicum Reports Second Quarter 2022 Financial Results and Provides Operational Update

    HOUSTON, Aug. 11, 2022 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (Nasdaq: BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers, today reported financial results for the second quarter 2022 and provided an operational update. “We have c...

  • BLCM - Bellicum Reports First Quarter 2022 Financial Results and Provides Operational Update

    HOUSTON, May 12, 2022 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (Nasdaq: BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers, today reported financial results for the first quarter 2022 and provided an operational update. “I am please...

  • BLCM - Watch for Continued Gains in Shares of Bellicum Pharmaceuticals Inc. (BLCM)

    Shares of Bellicum Pharmaceuticals Inc. (NASDAQ:BLCM) traded at a new 52-week high today of $23.11. This new high was reached on above average trading volume as 67.8 million shares traded hands, while the average 30-day volume is approximately 34,000 shares. Bellicum Pharmaceuticals Inc ...

  • Research
  • Stock Search
  • News Releases
  • Articles
  • Message Boards
  • Trending Stocks
  • Short Information
  • Stock Wall
  • Link Twitter
  • Coins
  • Link Twitter
  • Sign Up
  • Login
  • Contact

Article Banner Advertisement Program

Boost your Articles

The Banner Advertisement Program is designed to Boost your article through a targeted audience.

p>

Pricing and information can be found here.Coins

Each coin will allow 12 hours of Banner advertisement placement everywhere on the Market Wire News platform, included in all emails and other various CWN Media platformsIt also inclused pop up to any new visitor to the site..

Once you receive the coins you can start the advertisement by clicking the button located next to your article in your list of article in your list of articles.

Every twelve hours the ads will automatically stop. You may continue the advertisement for another twelve hours at any time by pressing the button located next to your article in your list of articles. Each time you continue a coin will be withdrawn from your account.

Sign up or login to continue

Sign up or login to continue.


Forgot password?




Mobile Number Subscribers

Market Wire News provides notifications to customers about updates, service, reminders, or products. Current and new customers of Market Wire News will enter their mobile numbers on a web opt-in form https://marketwirenews.com. Supported Carriers are as follows Alltel, AT&T, Cincinnati Bell, Dobson Cellular Systems, Inter Op, MetroPCS®, Nextel Communications, Sprint PCS, T-Mobile®, U.S. Cellular®, Verizon Wireless, and Virgin Mobile U.S. T-Mobile® is not liable for delayed or undelivered messages. There are no premium charges for joining Market Wire News service. Message and data rates may apply. Subscribers to Market Wire News service may receive up to 500 per month.

How to Opt Out

To opt-out of the Market Wire News program, send or text STOP, END, QUIT, CANCEL or UNSUBSCRIBE to (844) 931-3999. An unsubscribe message will be sent to your number confirming the cancellation, but no more messages will be sent after that one.

Mobile Support

For support or information about a Market Wire News, send or text HELP to (844) 931-3999. Optionally, you may email support@marketwirenews.com.

WATCH LIVE TRENDING STOCKS

Advertise

Brand your company, advertise your products or services with our ad programs.

Advertise

Research

Stock Search

News Releases

Articles

Message Boards

Trending Stocks

Short Information

Stock Wall

Members

Log In

Sign Up

Stay Connected

Follow @marketwirenews

| Facebook

| Telegram

| LinkedIn

| Reddit

| Discord


Contact

Privacy

Terms of Service

Disclaimer

© 2022 Market Wire News